Nomura Securities downgraded Pharmacyclics (NASDAQ: PCYC) from Buy to Neutral with a price target of $158.00 (from $175.00).Analyst M. Ian ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE